Clinical Medicine Books

Author: Dr Y. Robert Li

Publisher: Cell Med Press, AIMSCI Inc.; First edition (Paperback: March 11, 2018; Hardcover: May 1, 2018; Kindle: January 26, 2019)

Language: English

Product Dimensions: 8.5 (w) x 11 (h) x 0.66-0.9 (d) inches

Paperback: 266 pages (full colors) | ISBN-10: 1-68056-003-4 | ISBN-13: 978-1-68056-003-9

Hardcover: 266 pages (full colors) | ISBN-10: 1-68056-004-2 | ISBN-13: 978-1-68056-004-6

Kindle: 268 pages (full colors) | 23.5 MB

Written in an accessible style and consistent format, “Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013–2017)” takes a unique approach to integrating the fundamental concepts with high quality cutting-edge research discoveries and translating essential bioscience to evidence-based clinical medicine so as to provide the reader a comprehensive picture of this rapidly evolving field in a concise manner.

  • Blends basic and clinical sciences needed to effectively demonstrate the importance of the field
  • Includes full-color illustrations to facilitate the understanding of the essential concepts
  • Cites references mostly from highly influential journals to ensure the top quality of the information
  • Uses chapter highlights and self-assessment questions to enhance the assimilation of the cutting-edge knowledge
  • Serves as a valuable reference or textbook for students, faculty, clinician, and other health professionals in the fields of biomedical science, pharmacology, pharmacotherapeutics, and clinical medicine

Y. Robert Li is Professor and Chair of Pharmacology at Campbell Medical School and Adjunct Professor at several other major universities, including Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Department of Biomedical Sciences and Pathobiology of Virginia Polytechnic Institute and State University, and Department of Biology of University of North Carolina at Greensboro. Y. Robert Li is Co-Editor-in-Chief of Toxicology Letters, a well-respected international journal published by Elsevier and editorial board member for a number of major scholarly journals. He is author of over 130 peer-reviewed journal articles and his research has been funded extensively by the United States National Institutes of Health. Other recent books of Y. Robert Li include the widely adopted “Free Radical Biomedicine: Principles, Clinical Correlations, and Methodologies”; “Antioxidants in Biology and Medicine: Essentials, Advances, and Clinical Applications”; “Cardiovascular Diseases: From Molecular Pharmacology to Evidence-Based Therapeutics”; and “Biomedical Research: Strategic Planning for Success”.

PREFACE

UNIT I. DYSLIPIDEMIAS

Chapter 1. Overview of Dyslipidemias and Drug Therapy

Chapter 2. New Drugs for Hypercholesterolemia

Chapter 3. New Drugs for Hypertriglyceridemia

UNIT II. SYSTEMIC HYPERTENSION

Chapter 4. Overview of Hypertension and Drug Therapy

Chapter 5. New Drugs for Systemic Hypertension

UNIT III. PULMONARY HYPERTENSION

Chapter 6. Overview of Pulmonary Hypertension and Drug Therapy

Chapter 7. New Drugs for Pulmonary Hypertension

UNIT IV. ACUTE CORONARY SYNDROMES AND OTHER THROMBOTIC DISORDERS

Chapter 8. Overview of Acute Coronary Syndromes and Drug Therapy

Chapter 9. New Drugs for Acute Coronary Syndromes

Chapter 10. New Drugs for Other Thromboembolic Disorders

UNIT. VHEART FAILURE

Chapter 11. Overview of Heart Failure and Drug Therapy

Chapter 12. New Drugs for Heart Failure

INDEX